GLP2TZ – 10mg–60mg

Description

GLP2-TZ is a dual-agonist peptide studied for its interaction with GLP-1 and GIP receptors, key components of incretin-based signaling pathways. It is commonly examined in research involving receptor-mediated signaling, pathway modulation, and metabolic system modeling.

In laboratory settings, GLP2-TZ is utilized to investigate dual receptor activation and its effects on downstream signaling cascades and pathway communication. Its targeted activity across GLP-1 and GIP receptors provides a controlled framework for studying incretin pathway dynamics and receptor interaction.

GLP2-TZ has been explored in research involving:

• Dual incretin receptor signaling (GLP-1 and GIP)
• Receptor binding dynamics and activation patterns
• Signaling cascade modulation and pathway interaction
• Metabolic pathway modeling in controlled environments
• Peptide-mediated signaling system studies

Due to its focused receptor profile, GLP2-TZ is frequently used in research examining incretin pathway behavior and dual-receptor signaling interactions.

Each vial contains lyophilized GLP2-TZ intended strictly for laboratory research purposes.

Research Use Only (RUO). Not for human or veterinary use.